Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

NANO

Nanometrics (NANO)

Nanometrics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NANO
DateHeureSourceTitreSymboleSociété
09/08/202222h15Business WireNANOBIOTIX: Voting Rights and Shares Capital of the CompanyNASDAQ:NANONanometrics Inc
09/08/202222h15Business WireNANOBIOTIX : INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIALNASDAQ:NANONanometrics Inc
13/07/202222h15Business WireBILAN SEMESTRIEL 2022 DU CONTRAT DE LIQUIDITÉ NANOBIOTIX AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONTNASDAQ:NANONanometrics Inc
13/07/202222h15Business WireHalf-year Report on the Nanobiotix Liquidity Contract With Gilbert DupontNASDAQ:NANONanometrics Inc
08/07/202222h15Business WireNanobiotix : INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIALNASDAQ:NANONanometrics Inc
08/07/202222h15Business WireNanobiotix: Voting Rights and Shares Capital of the CompanyNASDAQ:NANONanometrics Inc
09/06/202222h15Business WireNANOBIOTIX: Statement of Total Voting Rights and Shares Forming the Company’s Share CapitalNASDAQ:NANONanometrics Inc
05/06/202215h00Business WireNANOBIOTIX : DE NOUVELLES DONNÉES ASSOCIANT NBTRX3 AVEC LA CHIMIOTHÉRAPIE EN PRÉOPÉRATOIRE INDIQUENT QUE NBTRX3 S’INTEGRERAIT DANS LE TRAITEMENT DU CANCER DE LA TÊTE ET DU COU ET D'AUTRES TUMEURS SOLIDESNASDAQ:NANONanometrics Inc
05/06/202215h00Business WireNANOBIOTIX: New Data Featuring NBTXR3 Plus Chemoradiation and in the Preoperative Setting Support Broad Applicability for Head and Neck Cancer and Other Solid Tumor IndicationsNASDAQ:NANONanometrics Inc
02/06/202222h15Business WireL’ASSEMBLÉE GÉNÉRALE MIXTE ANNUELLE DE NANOBIOTIX SE TIENDRA LE 23 JUIN 2022NASDAQ:NANONanometrics Inc
02/06/202222h15Business WireNANOBIOTIX Annual Shareholders’ General Meeting to Be Held on June 23, 2022NASDAQ:NANONanometrics Inc
19/05/202203h12Business WireCORRIGE ET REMPLACE : NANOBIOTIX FAIT LE POINT SUR SES ACTIVITÉS ET PUBLIE SES RÉSULTATS FINANCIERS POUR LE PREMIER TRIMESTRENASDAQ:NANONanometrics Inc
19/05/202203h12Business WireCORRECTING and REPLACING: NANOBIOTIX Provides First Quarter Operational and Financial UpdateNASDAQ:NANONanometrics Inc
18/05/202222h40Business WireNANOBIOTIX Provides First Quarter Operational and Financial UpdateNASDAQ:NANONanometrics Inc
18/05/202222h40Business WireNANOBIOTIX FAIT LE POINT SUR SES ACTIVITÉS ET PUBLIE SES RÉSULTATS FINANCIERS POUR LE PREMIER TRIMESTRENASDAQ:NANONanometrics Inc
17/05/202222h15Business WireNANOBIOTIX PARTICIPERA EN JUIN À LA CONFÉRENCE JEFFERIES HEALTHCARENASDAQ:NANONanometrics Inc
17/05/202222h15Business WireNANOBIOTIX to Present During the Jefferies Healthcare Conference in June 2022NASDAQ:NANONanometrics Inc
11/05/202222h15Business WireNANOBIOTIX to Participate in Two Upcoming Investor ConferencesNASDAQ:NANONanometrics Inc
11/05/202222h15Business WireNANOBIOTIX PARTICIPERA PROCHAINEMENT À DEUX CONFÉRENCES INVESTISSEURSNASDAQ:NANONanometrics Inc
10/05/202222h15Business WireNanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share CapitalNASDAQ:NANONanometrics Inc
02/06/202022h57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NANONanometrics Inc
29/05/202012h01Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:NANONanometrics Inc
19/05/202017h28Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NANONanometrics Inc
14/05/202020h19Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:NANONanometrics Inc
14/05/202018h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NANONanometrics Inc
05/05/202023h17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NANONanometrics Inc
03/04/202023h15Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NANONanometrics Inc
03/04/202023h12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NANONanometrics Inc
25/02/202021h39Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NANONanometrics Inc
12/02/202017h49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NANONanometrics Inc
 Showing the most relevant articles for your search:NASDAQ:NANO